GDF2 and metabolic dysfunction-associated steatotic liver disease: Additionally, BMP9 has been implicated in liver diseases, including nonalcoholic fatty liver disease (NAFLD), liver fibrosis, and hepatocellular carcinoma(HCC) [35].